Heesbeen Elise J, Bijlsma Elisabeth Y, Risseeuw Tristan A, Hessel Ellen V S, Groenink Lucianne
Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands (the).
Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands (the).
Brain Behav Immun. 2025 Jan;123:752-764. doi: 10.1016/j.bbi.2024.10.027. Epub 2024 Oct 21.
The pathophysiology of several neurodegenerative and neuropsychiatric disorders is linked to an altered immune system. However, it is often unclear how the immune system specifically affects these disorders since neuroimmune interactions are very complex. In this paper, we introduce an adjusted version of the adverse outcome pathway (AOP) approach from toxicology to the field of neuroimmunology. A review of the effect of TNF-α on fear learning deficits is used as a worked example to demonstrate how an AOP approach can help identify gaps of knowledge and crucial steps in the pathophysiology of neuroimmunological disorders.
The AOP was constructed in five steps. First, the adverse outcome was formulated clearly and specifically. Second, the link between the molecular initiating event and the adverse outcome was established with a preliminary literature search in the Medline database. Third, a systematic literature search was performed in which we identified 95 relevant articles. Fourth, the main biological processes and relevant key events were identified. Fifth, the links between key events were determined and an AOP network was constructed.
We identified three pathways through which TNF-α may affect fear learning. First, TNF-α receptor activation increases NF-κB levels which increases oxidative stress levels and reduces the activity of glutamate transporters. This alters the synaptic plasticity which is associated with impaired fear acquisition, consolidation, and fear extinction. Second, activation of TNF-α receptors increases the expression and capacity of the serotonin transporter which is linked to impaired fear acquisition, expression, and extinction. Third, TNF-α receptor 1 activation can induce necroptosis, leading to neuroinflammation which is linked to fear learning deficits.
To successfully apply the AOP approach in neuroimmunology we recommend defining adverse outcomes more precisely, establishing stronger connections between key events from various biological processes, incorporating feedforward and feedback loops, and identifying more mechanistic knowledge in later key events. These adjustments are needed to map the complex processes within the field of neuroimmunology and to identify gaps of knowledge.
几种神经退行性疾病和神经精神疾病的病理生理学与免疫系统改变有关。然而,由于神经免疫相互作用非常复杂,免疫系统如何具体影响这些疾病往往尚不清楚。在本文中,我们将毒理学中不良结局途径(AOP)方法的一个调整版本引入神经免疫学领域。以肿瘤坏死因子-α(TNF-α)对恐惧学习缺陷的影响综述为例,说明AOP方法如何有助于识别神经免疫疾病病理生理学中的知识空白和关键步骤。
AOP分五步构建。首先,清晰明确地阐述不良结局。其次,通过在医学文献数据库(Medline)中进行初步文献检索,建立分子起始事件与不良结局之间的联系。第三,进行系统的文献检索,我们共识别出95篇相关文章。第四,确定主要生物学过程和相关关键事件。第五,确定关键事件之间的联系并构建AOP网络。
我们确定了TNF-α可能影响恐惧学习的三条途径。首先,TNF-α受体激活会增加核因子-κB(NF-κB)水平,进而增加氧化应激水平并降低谷氨酸转运体的活性。这会改变突触可塑性,而突触可塑性与恐惧习得、巩固和消退受损有关。其次,TNF-α受体激活会增加血清素转运体的表达和能力,这与恐惧习得、表达和消退受损有关。第三,TNF-α受体1激活可诱导坏死性凋亡,导致神经炎症,这与恐惧学习缺陷有关。
为了在神经免疫学中成功应用AOP方法,我们建议更精确地定义不良结局,在来自不同生物学过程的关键事件之间建立更紧密的联系,纳入前馈和反馈回路,并在后续关键事件中识别更多的机制知识。需要进行这些调整来描绘神经免疫学领域内的复杂过程并识别知识空白。